130 related articles for article (PubMed ID: 10480666)
1. Latent structures underlying schizophrenic symptoms: a five-dimensional model.
Nakaya M; Suwa H; Ohmori K
Schizophr Res; 1999 Aug; 39(1):39-50. PubMed ID: 10480666
[TBL] [Abstract][Full Text] [Related]
2. Five-factor model of schizophrenic psychopathology: how valid is it?
Lykouras L; Oulis P; Psarros K; Daskalopoulou E; Botsis A; Christodoulou GN; Stefanis C
Eur Arch Psychiatry Clin Neurosci; 2000; 250(2):93-100. PubMed ID: 10853925
[TBL] [Abstract][Full Text] [Related]
3. [Dimensions of schizophrenic symptomatology. Comparative testing of several theoretical models in a first-episode population sample].
Löffler W; Häfner H
Nervenarzt; 1999 May; 70(5):416-29. PubMed ID: 10407837
[TBL] [Abstract][Full Text] [Related]
4. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients.
Fresán A; De la Fuente-Sandoval C; Loyzaga C; García-Anaya M; Meyenberg N; Nicolini H; Apiquian R
Schizophr Res; 2005 Jan; 72(2-3):123-9. PubMed ID: 15560957
[TBL] [Abstract][Full Text] [Related]
5. The Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
[TBL] [Abstract][Full Text] [Related]
6. Psychopathological dimensions in schizophrenia.
Cuesta MJ; Peralta V
Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
[TBL] [Abstract][Full Text] [Related]
7. Symptom structure in schizophrenia: two-, three- or four-factor models?
Dollfus S; Everitt B
Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
[TBL] [Abstract][Full Text] [Related]
8. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the factor structure of symptoms in patients with schizophrenia.
Kim JH; Kim SY; Lee J; Oh KJ; Kim YB; Cho ZH
Psychiatry Res; 2012 May; 197(3):285-9. PubMed ID: 22364933
[TBL] [Abstract][Full Text] [Related]
10. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model.
Peralta V; Cuesta MJ; de Leon J
Biol Psychiatry; 1994 Dec; 36(11):726-36. PubMed ID: 7858068
[TBL] [Abstract][Full Text] [Related]
11. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale.
Mass R; Schoemig T; Hitschfeld K; Wall E; Haasen C
Schizophr Bull; 2000; 26(1):167-77. PubMed ID: 10755679
[TBL] [Abstract][Full Text] [Related]
12. Factor structure and clinical validity of competing models of positive symptoms in schizophrenia.
Peralta V; Cuesta MJ
Biol Psychiatry; 1998 Jul; 44(2):107-14. PubMed ID: 9646892
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
Levine SZ; Rabinowitz J
J Clin Psychopharmacol; 2007 Oct; 27(5):431-6. PubMed ID: 17873671
[TBL] [Abstract][Full Text] [Related]
14. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
Xu K; Krystal JH; Ning Y; Chen DC; He H; Wang D; Ke X; Zhang X; Ding Y; Liu Y; Gueorguieva R; Wang Z; Limoncelli D; Pietrzak RH; Petrakis IL; Zhang X; Fan N
J Psychiatr Res; 2015 Feb; 61():64-72. PubMed ID: 25560772
[TBL] [Abstract][Full Text] [Related]
15. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models.
Peralta V; Cuesta MJ
Am J Psychiatry; 1995 Oct; 152(10):1450-7. PubMed ID: 7573583
[TBL] [Abstract][Full Text] [Related]
16. Dimensional approaches to schizophrenia: A comparison of the Bern Psychopathology scale and the five-factor model of the Positive and Negative Syndrome Scale.
Lang FU; Müller-Stierlin AS; Walther S; Stegmayer K; Becker T; Jäger M
Psychiatry Res; 2016 May; 239():284-90. PubMed ID: 27043275
[TBL] [Abstract][Full Text] [Related]
17. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
Marder SR; Davis JM; Chouinard G
J Clin Psychiatry; 1997 Dec; 58(12):538-46. PubMed ID: 9448657
[TBL] [Abstract][Full Text] [Related]
18. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia.
Stefanovics EA; Krystal JH; Rosenheck RA
Compr Psychiatry; 2014 May; 55(4):887-95. PubMed ID: 24602497
[TBL] [Abstract][Full Text] [Related]
19. The five symptom dimensions and depression in schizophrenia.
Lee KH; Harris AW; Loughland CM; Williams LM
Psychopathology; 2003; 36(5):226-33. PubMed ID: 14571051
[TBL] [Abstract][Full Text] [Related]
20. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].
Peralta Martín V; Cuesta Zorita MJ
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):171-7. PubMed ID: 7810373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
